Despite the existence of comprehensive severe asthma guidelines and a severe asthma registry, Japan’s score in Policy Context is well below the average due to the lack of a national asthma strategy and limited alignment of national care guidelines with international guidelines. Importantly, Japan ranks last in terms of Access and Care Coverage. This can be attributed to limited access to treatment and medicines (including biologics), diagnostics, and digital therapeutics. In spite of this, Japan has the highest score in Disease Burden, with relatively low scores across most indicators except the percentage of deaths attributable to asthma, where Japan ranks slightly below average and is driven primarily by the lowest rate of adult obesity among the selected countries.
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Japan
Provides further insights into how Japan scores across each Index category
Guidelines, strategies, and policies related to the management of severe asthma and health outcomes
Regulations and practices concerning public payor coverage for and availability of diagnostic and treatment services for severe asthma
Indicators related to clinical management and economic impact of severe asthma and recording of patient health data
Information about the health impact of severe asthma and severe asthma comorbidities
Factors impacting prevention, management, and exacerbations of severe asthma
Aggregate score across the 5 categories.
Explore how each of the 29 OECD countries scored in the Severe Asthma Index
Select different countries to see how they scored across each of the 5 categories and overall